Biomarker linked to increased survival rates among certain brain tumor patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Study shows DNA biomarker can be used to predict outcomes for high risk low grade gliomas

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Arnab Chakravarti
Chair, radiation oncology, The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Table of Contents

YOU MAY BE INTERESTED IN

Credit: Jonah Elkowitz/ShutterstockThat President Biden was diagnosed with prostate cancer is certainly unfortunate news, but it should come as no surprise. One in eight men in the U.S. will be told they have prostate cancer at some point in their lifetime: more than 300,000 new diagnoses occur annually, and the absolute numbers are rising. 
Arnab Chakravarti
Chair, radiation oncology, The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login